Skip to content

My Father, Attiq Rahman

FAMILY · CHEMISTRY · LEGACY

My Father, Attiq Rahman

A chemist, a father, and one of the foundations of The Rahman Lab.

Attiq Rahman with his son
Father and son.

My father, Attiq Rahman, was a medicinal chemist whose life and work
left a lasting influence on me.

He built his career in medicinal chemistry through research at
GlaxoSmithKline, where his work contributed to the development
of new chemical compounds with medicinal applications toward many diseases.

For me, however, his legacy goes far beyond any laboratory notebook, patent, or
chemical structure. He was my father. My own path through chemistry, research,
teaching, and this work I now call The Rahman Lab exists in part
because chemistry was something I grew up seeing him live, breathe, and repeat.


Family & Childhood

My mother and I next to our family car
My mom and I.
1989 Toyota Supra MK3
My childhood car, a 1989 Toyota Supra MK3, 7M-GE automatic.


A Life in Chemistry

My father’s work was rooted in medicinal chemistry; a subject where organic chemistry,
biology, and medicine meet. His career reflected the same idea that still drives much
of my own work; chemistry matters most when it is connected to something larger than
the reaction itself. Many of the compounds he made were designed with the purpose of
treating immuno-inflammatory illnesses, such as lupus and cancer. Tragically, my father
Attiq was diagnosed with Stage IV Colon Cancer in May 2018. Despite pursuing an
aggressive treatment regimen, the cancer had caused substantial damage, and he passed
away in July 2018.

His influence stayed with me as I studied chemistry during my undergraduate degree.
After waning at a few tough points, my interest in chemistry was rekindled by the rare
similarly-spirited professors who made learning fun again. As I progressed through
academic research and my degree, eventually teaching chemistry at Temple University,
I felt strongly to maintain a similar encouraging and open mindset in my own classroom.

Today; whether I am teaching students, rebuilding an old Kawasaki, developing a lab,
or working through a synthesis, some part of my dad’s story is still there.


Selected Publications

During his career at GlaxoSmithKline, my father contributed to published work spanning
synthetic organic chemistry, cysteine protease inhibitors, calcium receptor antagonists,
immuno-inflammatory medicinal chemistry, and RIP1 kinase drug discovery.

An Efficient Synthesis of 3-Substituted 3H-Pyrimidin-4-ones

Co-author: Attiq Rahman

Organic Letters, 2004, 6(6), 1013–1016

DOI: 10.1021/ol049921v

Azepanone-Based Inhibitors of Human Cathepsin L

Co-author: Attiq Rahman

Journal of Medicinal Chemistry, 2005, 48(22), 6870–6878

DOI: 10.1021/jm0502079

Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues

Co-author: Attiq Rahman

Journal of Medicinal Chemistry, 2009, 52(21), 6599–6605

DOI: 10.1021/jm900563e

Synthesis of Tetrasubstituted Pyrazines and Pyrazine N-Oxides

Co-author: Attiq Rahman

Tetrahedron Letters, 2010, 51, 974–976

DOI: 10.1016/j.tetlet.2009.12.053

Azepanone-Based Inhibitors of Human Cathepsin S: Optimization of Selectivity via the P2 Substituent

Co-author: Attiq Rahman

Bioorganic & Medicinal Chemistry Letters, 2011, 21, 4409–4415

DOI: 10.1016/j.bmcl.2011.06.045

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

Co-author: Attiq Rahman

Journal of Medicinal Chemistry, 2017, 60, 1247–1261

DOI: 10.1021/acs.jmedchem.6b01751


Patents

His work also continued into patented medicinal chemistry involving cyclic GMP-AMP
synthase, or cGAS, a target involved in immune signaling and inflammatory disease.

Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors

International patent publication

Patent No.: WO 2024/083773 A1

Published: April 25, 2024

Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors

United States patent

Patent No.: US 12,247,033 B2

Granted: March 11, 2025


Remembered at GlaxoSmithKline

After reading his obituary from GSK, I learned more about the breadth of the work my
father had carried out during his career there. GSK shared the following remembrance:

Attiq was a medicinal chemist with nearly 20 years of experience. He joined GSK in
1998 as a co-op student and had impressed management sufficiently to secure a fulltime
offer. Over the next 20 years, he contributed to a number of programs including CatK,
CaSR, TRPV4, RIP2, RIP1 and STING. During the last few years, Attiq was involved in
the cGAS program and was a key contributor to the current class of lead molecules.

Attiq will be dearly missed by his friends and colleagues across the organization.
Those who knew him well said how much they will miss his positive outlook on life,
warm smile and kind and friendly disposition.

GSK memorial for Attiq Rahman
At my father’s memorial at GlaxoSmithKline.

The Rahman Lab is not only about my current chemistry research. It is also about who caused that initial spark of curiosity, decades ago.

His Legacy

My father passed down more than an interest in science. He passed down an example of
intellectual curiosity, technical skill, and the belief that difficult problems are
worth working through.

His influence continues in the way I approach chemistry, education, research, and
problem solving. The work may be different now, but his mindset remains familiar;
look carefully around you, focus and try to understand the puzzle, study; and keep
working until it makes sense.

This page is here to preserve a small part of that story, not simply as the story of
a scientist, but as the story of my father, Attiq Rahman.